Daclacruz 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.
Daclacruz 60mg Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with or without food, preferably at a fixed time. Do not skip any doses and finish the full course of treatment even if you feel better If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
It has fewer side effects as compared to other similar medicines, like fatigue, headache, nausea, insomnia (difficulty sleeping), and anemia (low red blood cell count). Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding.
Uses of Daclacruz Tablet
Chronic hepatitis C virus (HCV) infection
Benefits of Daclacruz Tablet
In Chronic hepatitis C virus (HCV) infection
Daclacruz 60mg Tablet works by preventing the HCV virus from multiplying in your body. It helps control the infection and makes the immune system work better. This lowers your chances of getting complications and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines. It is not a cure and should neither be used to prevent HCV infection. You must take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of the medicine.
Side effects of Daclacruz Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Daclacruz
Fatigue
Headache
Nausea
Insomnia (difficulty in sleeping)
Anemia (low number of red blood cells)
How to use Daclacruz Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Daclacruz 60mg Tablet may be taken with or without food.
How Daclacruz Tablet works
Daclacruz 60mg Tablet is an antiviral medication. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Daclacruz 60mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
The safety of Daclacruz 60mg Tablet during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breast feeding
SAFE IF PRESCRIBED
Daclacruz 60mg Tablet may be safe to use during breastfeeding. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Driving
CONSULT YOUR DOCTOR
It is not known whether Daclacruz 60mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
Kidney
SAFE IF PRESCRIBED
Daclacruz 60mg Tablet is safe to use in patients with kidney disease. No dose adjustment is recommended.
Liver
SAFE IF PRESCRIBED
Daclacruz 60mg Tablet is safe to use in patients with liver disease. No dose adjustment is recommended.
What if you forget to take Daclacruz Tablet?
If you miss a dose of Daclacruz 60mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Do not consume Daclatasvir with Amiodarone. If concurrent use is essential, watch out for symptoms such as breathlessness, fatigue, drowsiness, sedation, faintness, or vomiting, an... More
Do not consume Daclatasvir with Amiodarone. If concurrent use is essential, watch out for symptoms such as breathlessness, fatigue, drowsiness, sedation, faintness, or vomiting, an... More
Watch out for symptoms such as muscle aches or weakness and consult your doctor if you experience them. Simvastatin may increase the side effects of Daclatasvir.
Watch out for symptoms of Fexofenadine side effects such as headaches, excessive sleepiness, dry mouth, feeling sick or dizziness and consult your doctor if you experience them. Th... More
https://www.1mg.com/otc/himalaya-liv.-52-ds-tablet-otc135545One ?one tablet morning & evening after taking food , use at least 1-2 monthsUse this medicine along with your treatment
I am affected from hepatitis c virus diagnosed with confirmed genotype. Meanwhile i am pregnant will hepatitis virus pass on my baby. Or i should abort
Dr. Kunal Parasar
Surgical Gastroenterology
Your reports are of february with no ongoin liver damage. You havnt got the quantitative analysis. Most probably you wont need to abort. But be in constant follow up of good gastroenterologist near you.
Dear sir homeopathy can be taken as Add-on therapy in your case which shall improve your quality of life and decrease the progression of disease. You can visit a homeopath for detailed discussion and treatment
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Daclatasvir. 2022 Feb 7. [Accessed 29 Dec. 2025]. Available from: